In the quiet pampas town of San Antonio de Areco, a small Argentine company has quietly rewritten what it means to breed a living creature. Kheiron, founded in 2011, has used cloning and CRISPR-Cas9 gene editing to produce horses that now dominate elite polo worldwide — and pigs whose organs may one day bridge the gap between a dying patient and a donor. When U.S. Department of Agriculture officials traveled there to witness it firsthand, it was a quiet acknowledgment that the future of genetic science is not always found where the world expects it.
Clarin.com
· Jun 07, 2026
· technology
· 3 min de lectura
High
Verificación: Verificado
Argentine biotech firm Kheiron leads global equine cloning, impresses U.S. delegation
The pig genetic modifications aim to improve organ transplant availability for human patients awaiting donor organs.
◉
Business
516 artículos relacionados
WTTC to establish permanent Madrid headquarters, hiring 45 internation…
LA RAZÓN · 80% coincidencia
Pink Albatross seeks creditor protection as vegan ice cream startup ba…
El Español · 70% coincidencia
Orange completes €4.25B acquisition to gain full control of MasOrange
Google News · 70% coincidencia
Iberdrola celebra junta con récord de beneficios y ratifica a Azagra
Castellón Plaza · 70% coincidencia
Google planea mayor inversión en IA para Search en 2025 pese a caída d…
Digital Trends Español · 70% coincidencia
Cobertura Relacionada
El Ecosistema Startup · Aug 21
HR Startup Competition 2026: plazo hasta el 13 de septiembre para startups de recursos humanos
RRHHDigital abre la convocatoria de la HR Startup Competition 2026 para startups Early Stage en soluciones de gestión de…
Fichajes.com · Aug 21 Atlético Madrid cierra definitivamente la puerta a la salida de Julián ÁlvarezEl CEO del Atlético de Madrid, Miguel Ángel Gil Marín, confirmó que el club se quedará con Julián Álvarez pese a los int…
La Vanguardia · Aug 20 Altum Sequencing ultim a ronda de 5 millones para expandir su 'radar' contra el cáncerLa startup Altum Sequencing ultima una ronda de 5 millones de euros para expandir internacionalmente su tecnología de bi…
Funds Society · Aug 19 Multiplica: la AFP digital que revoluciona el sistema de pensiones en ChileMultiplica, una nueva AFP nativa digital respaldada por emprendedores chilenos, busca transformar el sistema de pensione…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
🌎
Argentine biotech firm Kheiron's equine cloning leadership attracts U.S. USDA delegation, positioning Argentina as a global biotechnology hub and potential strategic partner in agricultural innovation.
Escalation Risk
low
Confidence
HIGH
Argentina
United States
Global agricultural markets
Latin America
Argentina gains soft power and technological prestige through biotech leadership, attracting U.S. government and commercial interest. U.S. seeks to establish partnerships with Argentine biotech capabilities, potentially to secure access to advanced genetic technologies and maintain competitive advantage in agricultural biotechnology.
Similar to Brazil's rise in agricultural technology leadership (sugarcane genetics, precision farming) in the 1990s-2000s, which elevated its geopolitical influence in trade negotiations and technology partnerships.
Lente Económico
📈
Argentine biotech firm Kheiron's cloning and genetic editing breakthroughs position Argentina as a global leader in equine biotechnology, attracting U.S. government interest and potential export opportunities.
Market Signal
bullish
Confidence
HIGH
Biotechnology and genetic engineering
Agriculture and livestock
Equestrian sports and breeding
Pharmaceutical and organ transplantation
International trade and exports
Consumers may benefit from advanced organ transplant technologies developed through xenotransplantation research, potentially reducing transplant waiting times and improving healthcare outcomes. Equestrian enthusiasts gain access to genetically optimized horses, though at premium prices.
Argentina may attract increased biotech investment and international partnerships. U.S. delegation visit suggests potential regulatory harmonization discussions and export agreements. Governments may need to establish frameworks for genetic modification oversight, ethical guidelines for animal cloning, and intellectual property protections for biotechnology innovations.